Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine

Cited by (1,001)

Items 801–900 of 1,001

1. The Pathophysiology of Virulence of the COVID-19 Virus
   Joseph De Soto, Shazia Tabassum Hakim, Frederick Boyd · 2020 · Preprints.org
2. Population genomics insights into the recent evolution of SARS-CoV-2
   Maria Vasilarou, Nikolaos Alachiotis, Joanna Garefalaki, Apostolos I. Beloukas, Pavlos Pavlidis · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
3. Emergence of multiple variants of SARS-CoV-2 with signature structural changes
   Debaleena Bhowmik, Sourav Pal, Abhishake Lahiri, Arindam Talukdar, Sandip Paul · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
4. Isolation of and Characterization of Neutralizing Antibodies to Covid-19 from a Large Human Naïve scFv Phage Display Library
   Andy Qingan Yuan, Likun Zhao, Lili Bai, Qingwu Meng, Zhenguo Wen, Yanhu Li, Daqing Guo, Shanshan Zhen, Xiaojun Chen, Ji Yang et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
5. SARS-CoV-2 inhibition in human airway epithelial cells using a mucoadhesive, amphiphilic chitosan that may serve as an anti-viral nasal spray
   Krzysztof Pyrć, Aleksandra Milewska, Emilia Barreto-Durán, Paweł Botwina, Rui M. Lopes, Alejandro Arenas‐Pinto, Moutaz Y. Badr, Ryan D. Mellor, Tammy L. Kalber, Delmiro Fernández-Reyes et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
6. Exploring conformational landscapes and binding mechanisms of convergent evolution for the SARS-CoV-2 spike Omicron variant complexes with the ACE2 receptor using AlphaFold2-based structural ensembles and molecular dynamics simulations
   Nishank Raisinghani, Mohammed Alshahrani, Grace Gupta, Sian Xiao, Peng Tao, Gennady M. Verkhivker · 2024 · Physical Chemistry Chemical Physics
7. Nanobody peptide conjugate: a novel CD163 based broad neutralizing strategy against porcine reproductive and respiratory syndrome virus
   Haotian Yang, Meiqi Sun, He Qiu, Hui-Ling Xu, Zhuofan Deng, Han Gu, Nan Wang, Liuyang Du, Fushan Shi, Jiyong Zhou et al. · 2024 · Journal of Nanobiotechnology
8. Quantitative Characterization and Prediction of the Binding Determinants and Immune Escape Hotspots for Groups of Broadly Neutralizing Antibodies Against Omicron Variants: Atomistic Modeling of the SARS-CoV-2 Spike Complexes with Antibodies
   Mohammed Alshahrani, Vedant Parikh, Brandon Foley, Nishank Raisinghani, Gennady M. Verkhivker · 2025 · Biomolecules
9. Case series and review of liver dysfunction in COVID-19 patients
   Pujitha Kudaravalli, Sheikh A. Saleem, Bashar Ibeche, Savio John · 2020 · European Journal of Gastroenterology & Hepatology
10. Clinical Characteristics and Eosinophils in Young SARS-CoV-2-Positive Chinese Travelers Returning to Shanghai
    Juan Yang, Xiaohui Zhao, Xueyuan Liu, Wanju Sun, Longzhu Zhou, Yongbing Wang, Haijing Sui · 2020 · Frontiers in Public Health
11. Molecular characterization of interactions between the D614G variant of SARS-CoV-2 S-protein and neutralizing antibodies: A computational approach
    Alexander Kwarteng, Ebenezer Asiedu, Augustina Angelina Sylverken, Amma Aboagyewa Larbi, Samuel Asamoah Sakyi, Samuel Opoku Asiedu · 2021 · Infection Genetics and Evolution
12. Computational analysis of protein stability and allosteric interaction networks in distinct conformational forms of the SARS-CoV-2 spike D614G mutant: reconciling functional mechanisms through allosteric model of spike regulation
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · Journal of Biomolecular Structure and Dynamics
13. The Complex Interplay between Immunonutrition, Mast Cells, and Histamine Signaling in COVID-19
    Sotirios Kakavas, Dimitrios Karayiannis, Zafeiria Mastora · 2021 · Nutrients
14. Excavating phytochemicals from plants possessing antiviral activities for identifying SARS-CoV hemagglutinin-esterase inhibitors by diligent computational workflow
    Chirag Patel, Dweipayan Goswami, Dharmesh G. Jaiswal, Siddhi P. Jani, Robin M. Parmar, Rakesh Rawal, Himanshu A. Pandya · 2022 · Journal of Biomolecular Structure and Dynamics
15. Evaluation of a Functional Single Nucleotide Polymorphism of the SARS-CoV-2 Receptor ACE2 That Is Potentially Involved in Long COVID
    Yu-Si Luo, Lei Luo, Wěi Li, Yan Chen, Guofeng Wu, Fang Chen, Hu-Yan Shen, Hong-Man Li, Ming-Yang Guo, Yin Sha et al. · 2022 · Frontiers in Genetics
16. Lymphocyte count is a universal predictor of health outcomes in COVID-19 patients before mass vaccination: A meta-analytical study
    Kuan-Lang Lai, Fu‐Chang Hu, Fang-Yu Wen, Ju-Ju Chen · 2022 · Journal of Global Health
17. Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
    Ji Woong Kim, Sung Won Min, Jichul Lee, Ha Gyeong Shin, Hye Lim Choi, Ha Rim Yang, Ji Hyun Lee, Yea Bin Cho, Hyunbo Shim, Sukmook Lee · 2022 · Biomedicines
18. Intestinal Damage, Inflammation and Microbiota Alteration during COVID-19 Infection
    Angela Saviano, Mattia Brigida, Carmine Petruzziello, Christian Zanza, Marcello Candelli, Maria Rita Morabito Loprete, Faiz Saleem, Veronica Ojetti · 2023 · Biomedicines
19. Plausibility of natural immunomodulators in the treatment of COVID-19–A comprehensive analysis and future recommendations
    Raushanara Akter, Md. Rashidur Rahman, Zainab Syed Ahmed, Afrina Afrose · 2023 · Heliyon
20. Preclinical evaluation of general toxicity and safety pharmacology of a receptor-binding domain-based COVID-19 subunit vaccine in various animal models
    Sang‐Jin Park, Min Seong Jang, Kwang-Hyun Lim, Joung‐Wook Seo, Wan‐Jung Im, Kang-Hyun Han, Seong‐Eun Kim, Eunhee Jang, Danbi Park, Yong‐Bum Kim · 2023 · Archives of Toxicology
21. SARS-CoV-2 receptor ACE2 and molecular pathway to enter target cells during infection
    Khadijeh Najafi, Parham Maroufi, Ehsaneh Khodadadi, Elham Zeinalzadeh, Khudaverdi Ganbarov, Mohammad Asgharzadeh, Hossein Samadi Kafil · 2020 · Reviews in Medical Microbiology
22. Plausible blockers of Spike RBD in SARS-CoV2—molecular design and underlying interaction dynamics from high-level structural descriptors
    Sankar Basu, Devlina Chakravarty, Dhananjay Bhattacharyya, Pampa Saha, Hirak Kumar Patra · 2021 · Journal of Molecular Modeling
23. Comparative docking studies to understand the binding affinity of nicotine with soluble ACE2 (sACE2)-SARS-CoV-2 complex over sACE2
    Selvaa Kumar C, Senthil Arun Kumar, Haiyan Wei · 2020 · Toxicology Reports
24. Enhanced sampling protocol to elucidate fusion peptide opening of SARS-CoV-2 spike protein
    Jacob M. Remington, Kyle T. McKay, Jonathon B. Ferrell, Severin T. Schneebeli, Jianing Li · 2021 · Biophysical Journal
25. Prophylactic and therapeutic potential of selected immunomodulatory agents from Ayurveda against coronaviruses amidst the current formidable scenario: an in silico analysis
    Anchal Trivedi, Rumana Ahmad, Sahabjada Siddiqui, Aparna Misra, Mohsin Ali Khan, Aditi Srivastava, Tanveer Ahamad, Mohammad Faheem Khan, Zeba Siddiqi, Gazala Afrin et al. · 2021 · Journal of Biomolecular Structure and Dynamics
26. Computational modeling of protein conformational changes - Application to the opening SARS-CoV-2 spike
    Anna Kucherova, Selma Strango, Shahar Sukenik, Maxime Theillard · 2021 · Journal of Computational Physics
27. Computational anti-COVID-19 drug design: progress and challenges
    Jinxian Wang, Ying Zhang, Wenjuan Nie, Yi Luo, Lei Deng · 2021 · Briefings in Bioinformatics
28. Computational Insights into the Allosteric Effect and Dynamic Structural Features of the SARS‐COV‐2 Spike Protein
    Qiao Xue, Xian Liu, Wenxiao Pan, Aiqian Zhang, Jianjie Fu, Guibin Jiang · 2021 · Chemistry - A European Journal
29. SARS-CoV-2: Vaccinology and Emerging therapeutics; Challenges and Future Developments
    Adedapo M. Adesokan, Mohammad A. Obeid, Aisha Funmilayo Lawal · 2022 · Therapeutic Delivery
30. Genomic diversity and evolution of coronavirus (SARS-CoV-2) in France from 309 COVID-19-infected patients
    Anthony Levasseur, Jérémy Delerce, Aurélia Caputo, Ludivine Bréchard, Philippe Colson, Jean‐Christophe Lagier, Pierre‐Edouard Fournier, Didier Raoult · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
31. COVID-19 Pandemic and Vaccines
    H. Qaiser, R. Abdullah, T. Iftikhar, Hammad Majeed, I. Imran · 2021 · Alternative Medicine Interventions for COVID-19
32. Evolutionary pathways to SARS-CoV-2 resistance are opened and closed by epistasis acting on ACE2
    Gianni M. Castiglione, Lingli Zhou, Zhenhua Xu, Zachary M. Neiman, Chien‐Fu Hung, Elia J. Duh · 2021 · PLoS Biology
33. A rapid bead-based assay for screening of SARS-CoV-2 neutralizing antibodies
    Santhik Subhasingh Lupitha, Pramod Darvin, Aneesh Chandrasekharan, Shankara Narayanan Varadarajan, Soumya Jaya Divakaran, Easwaran Sreekumar, Shijulal Nelson Sathi, Perunthottathu K. Umasankar, Sara Jones, Iype Joseph et al. · 2022 · Antibody Therapeutics
34. The beneficial role of Hepcidin peptide inhibitor in improved the symptoms of COVID-19 in diabetics: anti-inflammatory and potential therapeutic effects
    Motahareh Zeinivand, Nida Jamali-Raeufy, Fahime Zavvari · 2022 · Journal of Diabetes & Metabolic Disorders
35. Arylcoumarin perturbs SARS-CoV-2 pathogenesis by targeting the S-protein/ACE2 interaction
    Ruhar Singh, Abhijeet Kumar, Jitendra Subhash Rane, Rajni Khan, Garima Tripathi, Amrendra K. Ajay, Amresh Prakash, Shashikant Ray · 2022 · Scientific Reports
36. Peptide microarray IgM and IgG screening of pre-SARS-CoV-2 human serum samples from Zimbabwe for reactivity with peptides from all seven human coronaviruses: a cross-sectional study
    Jordan Ashworth, Dayna Mathie, Fiona Scott, Yuvaraj Mahendran, Mark E. J. Woolhouse, Oda Stoevesandt, Takafira Mduluza, Francisca Mutapi · 2023 · The Lancet Microbe
37. Computational analysis of spike protein of SARS-CoV-2 (Omicron variant) for development of peptide-based therapeutics and diagnostics
    Manisha Pritam, Somenath Dutta, Krishna Mohan Medicherla, Rajnish Kumar, Satarudra Prakash Singh · 2023 · Journal of Biomolecular Structure and Dynamics
38. Electrochemical Immunosensors on Laser-Induced Graphene Platforms for Monitoring of Anti-RBD Antibodies After SARS-CoV-2 Infection
    Beatriz Rodrigues Martins, Cristhianne Molinero Andrade Ratkevicius, Guilherme F. Simão, Rhéltheer de Paula Martins, Lucas V. de Faria, Tiago A. Matias, Virmondes Rodrigues, Rodrigo A.A. Muñoz, Renata Pereira Alves · 2024 · Biosensors
39. Photonic Crystal Fiber Sensor with Molecular Docking Analysis to Evaluate Silica Efficacy for SARS-CoV-2 Spike Protein Detection in COVID-19
    V. Devika, M.S. Mani Rajan, S. Saravana Veni, P. Chandra Sekar · 2024 · Sensing and Imaging
40. Diabetes and Novel Coronavirus Infection: Implications for Treatment
    David M. Williams, Asif Nawaz, Marc Evans · 2020 · Diabetes Therapy
41. COVID-19: benefits and risks of passive immunotherapeutics
    Ankur Gupta, Rashmi Karki, Himanshu R. Dandu, Kuldeep Dhama, Madan LB Bhatt, Shailendra Kumar Saxena · 2020 · Human Vaccines & Immunotherapeutics
42. Gene expression network analysis provides potential targets against SARS-CoV-2
    Ana I. Hernández Cordero, Xuan Li, Chen Xi Yang, Stephen B Milne, Yohan Bossé, Philippe Joubert, Wim Timens, Maarten van den Berge, David C. Nickle, Ke Hao et al. · 2020 · Scientific Reports
43. Adjusting extracellular pH to prevent entry of SARS-CoV-2 into human cells
    Bin Wang · 2021 · Genome
44. Mechanisms of COVID-19 Entry into the Cell: Potential Therapeutic Approaches based on Virus Entry Inhibition in COVID-19 Patients with Underlying Diseases
    Hadis Musavi, Omid Abazari, Mohamad Sadegh Safaee, Atena Variji, Bahare Koohshekan, Fatemeh Kalaki-Jouybari, Zeinab Barartabar, Pejman Hakemi, Soleiman Mahjoub · 2021 · Iranian Journal of Allergy Asthma and Immunology
45. Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection
    Rohan Ameratunga, See‐Tarn Woon, Richard Henderson Steele, Russell G. Snell, Natalie J. Medlicott, Emily Mears, Euphemia Yee Leung, Klaus Lehnert, Anthony Jordan, Shyamal C. Das et al. · 2021 · Expert Review of Clinical Immunology
46. COVID-19 and SARS-CoV-2: Everything we know so far – A comprehensive review
    Sumaira Naz, Muhammad Zahoor, Muhammad Umar Khayam Sahibzada, Riaz Ullah, Ali Saeed Alqahtani · 2021 · Open Chemistry
47. Landscape-Based Mutational Sensitivity Cartography and Network Community Analysis of the SARS-CoV-2 Spike Protein Structures: Quantifying Functional Effects of the Circulating D614G Variant
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · ACS Omega
48. Systemic DPP4/CD26 is associated with natural HIV-1 control: Implications for COVID-19 susceptibility
    Yashini Govender, Sharon Shalekoff, Osman Ebrahim, Ziyaad Waja, Richard E. Chaisson, Neil Alexander Martinson, Caroline T. Tiemessen · 2021 · Clinical Immunology
49. Atomistic Simulations and In Silico Mutational Profiling of Protein Stability and Binding in the SARS-CoV-2 Spike Protein Complexes with Nanobodies: Molecular Determinants of Mutational Escape Mechanisms
    Gennady M. Verkhivker, Steve Agajanian, Deniz Yaşar Öztaş, Grace Gupta · 2021 · ACS Omega
50. Curcumin Analogues as a Potential Drug against Antibiotic Resistant Protein, β-Lactamases and L, D-Transpeptidases Involved in Toxin Secretion in Salmonella typhi: A Computational Approach
    Tanzina Akter, Mahim Chakma, Afsana Yeasmin Tanzina, Meheadi Hasan Rumi, Mst. Sharmin Sultana Shimu, Md. Abu Saleh, Shafi Mahmud, Saad Ahmed Sami, Talha Bin Emran · 2021 · BioMedInformatics
51. A rapid and affordable point of care test for antibodies against SARS-CoV-2 based on hemagglutination and artificial intelligence interpretation
    Vanessa Redecke, Kazuki Tawaratsumida, Erin T. Larragoite, Elizabeth S. C. P. Williams, Vicente Planelles, Adam M. Spivak, Lincoln Hirayama, Marc Elgort, Shane Swenson, Rick M. Smith et al. · 2021 · Scientific Reports
52. COVID-19: Immune response
    Hyam Raouf Al-Hamamy · 2022 · Research Journal of Pharmacy and Technology
53. Receptor-Binding-Motif-Targeted Sanger Sequencing: a Quick and Cost-Effective Strategy for Molecular Surveillance of SARS-CoV-2 Variants
    Sankar Prasad Chaki, Melissa M. Kahl-McDonagh, Benjamin W. Neuman, Kurt A. Zuelke · 2022 · Microbiology Spectrum
54. Computational Design of Miniprotein Inhibitors Targeting SARS-CoV-2 Spike Protein
    Jianhua Wu, Jilong Zhang, Hong‐Xing Zhang · 2022 · Langmuir
55. ZnO-chlorogenic acid nanostructured complex inhibits Covid-19 pathogenesis and increases hydroxychloroquine efficacy
    Mosleh Mohammad Abomughaid, Mohammed S. Nofal, Khaled Ismail Ghaleb, Mohamed Gomaa Seadawy, M.A. Wahab, Alaa S. Hegazy, Doaa Ahmad Ghareeb · 2022 · Journal of King Saud University - Science
56. Utilization of Receptor-Binding Domain of SARS-CoV-2 Spike Protein Expressed in Escherichia coli for the Development of Neutralizing Antibody Assay
    Termsak Tantiwiwat, Apisitt Thaiprayoon, Ake‐kavitch Siriatcharanon, Chakrit Tachaapaikoon, Nongluk Plongthongkum, Dujduan Waraho‐Zhmayev · 2022 · Molecular Biotechnology
57. Molecular Docking and Dynamics Simulation of Several Flavonoids Predict Cyanidin as an Effective Drug Candidate against SARS-CoV-2 Spike Protein
    Asmita Shrestha, Rishab Marahatha, Saroj Basnet, Bishnu P. Regmi, Saurav Katuwal, Salik Ram Dahal, Khaga Raj Sharma, Achyut Adhikari, Ram Chandra Basnyat, Niranjan Parajuli · 2022 · Advances in Pharmacological and Pharmaceutical Sciences
58. Exploring Conformational Landscapes and Cryptic Binding Pockets in Distinct Functional States of the SARS-CoV-2 Omicron BA.1 and BA.2 Trimers: Mutation-Induced Modulation of Protein Dynamics and Network-Guided Prediction of Variant-Specific Allosteric Binding Sites
    Gennady M. Verkhivker, Mohammed Alshahrani, Grace Gupta · 2023 · Viruses
59. Mass Spectrometry and Structural Biology Techniques in the Studies on the Coronavirus-Receptor Interaction
    Danuta Witkowska · 2020 · Molecules
60. Longitudinal analysis to characterize classes and subclasses of antibody responses to recombinant receptor-binding protein (RBD) of SARS-CoV-2 in COVID-19 patients in Thailand
    Sarunporn Tandhavanant, Sirikamon Koosakunirand, Taniya Kaewarpai, Watcharapong Piyaphanee, Pornsawan Leaungwutiwong, Viravarn Luvira, Narisara Chantratita · 2021 · PLoS ONE
61. Molecular Dynamics Studies on the Structural Characteristics for the Stability Prediction of SARS-CoV-2
    Kwang-Eun Choi, Jeong‐Min Kim, Jee Eun Rhee, Ae Kyung Park, Eun‐Jin Kim, Nam Sook Kang · 2021 · International Journal of Molecular Sciences
62. SARS-CoV-2 and diabetes: A potential therapeutic effect of dipeptidyl peptidase 4 inhibitors in diabetic patients diagnosed with COVID-19
    Zemene Demelash Kifle, Alem Endeshaw Woldeyohanins, Chilot Abiyu Demeke · 2021 · Metabolism Open
63. Hypozincemia in COVID-19 Patients Correlates With Stronger Antibody Response
    Wenye Xu, Ying-Zhi Liu, X. Zou, Huan-Le Luo, Wei-Hua Wu, Jun-Jie Xia, M. T. Chan, S. Fang, Yuelong Shu, W. Wu et al. · 2022 · Frontiers in Immunology
64. Oral Immunization of Mice with Cell Extracts from Recombinant Lactococcus lactis Expressing SARS-CoV-2 Spike Protein
    Biao Xuan, Jongbin Park, Jeong Ho Yoo, Eun Bae Kim · 2022 · Current Microbiology
65. Neutralizing antibodies and their cocktails against SARS-CoV-2 Omicron and other circulating variants
    Yang Yang, Lanying Du · 2022 · Cellular and Molecular Immunology
66. Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study
    Ahmad Farouk Eweas, Hosam-Eldin Hussein Osman, Ibrahim Ahmed Naguib, Mohammed A. S. Abourehab, Ahmed Sayed Abdel-Moneim · 2022 · Current Issues in Molecular Biology
67. Functional mutations of SARS-CoV-2: implications to viral transmission, pathogenicity and immune escape
    Shengyuan Dang, Lili Ren, Jianwei Wang · 2022 · Chinese Medical Journal
68. Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
    Jamille Ramos Oliveira, César Remuzgo, Rafael Rahal Guaragna Machado, Jhosiene Yukari Magawa, Isabela Pazotti Daher, Alysson H. Urbanski, Gabriela Justamante Händel Schmitz, Helen Andrade Arcuri, Marcelo Alves Ferreira, Greyce Luri Sasahara et al. · 2023 · Frontiers in Immunology
69. A brief molecular insight of COVID-19: epidemiology, clinical manifestation, molecular mechanism, cellular tropism and immuno-pathogenesis
    Sweta Singh, Rakesh Pandey, Sarika Tomar, Raunak Varshney, Darshika Sharma, Gurudutta Gangenahalli · 2021 · Molecular and Cellular Biochemistry
70. RPA-Based Method For The Detection Of SARS-COV2
    Angus A. Nassir, Mazarati Jean Baptiste, Ivan Emile Mwikarago, Majidi R. Habimana, Janvier Ndinkabandi, Anthère Murangwa, Thierry Nyatanyi, Claude Mambo Muvunyi, Sabin Nsanzimana, Léon Mutesa et al. · 2020 · medRxiv
71. How Does Arbidol Inhibit the Novel Coronavirus SARS-CoV-2? Atomistic Insights from Molecular Dynamics Simulations
    Aditya Kumar Padhi, Aniruddha Seal, Timir Tripathi · 2020 · ChemRxiv
72. Synthetic repertoires derived from convalescent COVID-19 patients enable discovery of SARS-CoV-2 neutralizing antibodies and a novel quaternary binding modality
    Jule Goike, Ching‐Lin Hsieh, Andrew P. Horton, Elizabeth C. Gardner, Foteini Bartzoka, Nianshuang Wang, Kamyab Javanmardi, Andrew S. Herbert, Shawn A. Abbasi, Rebecca L. Renberg et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
73. SARS-CoV-2 Nanovaccine Composed of Microfluidic-Produced Gold Nanoparticles Induces Neutralizing Immune Responses
    Natália Cristina Dalibera, Mônica Josiane Rodrigues‐Jesus, Robert Andreata‐Santos, Luiz Mário Ramos Janini, Aline Furtado Oliveira, Adriano Rodrigues Azzoni, Luís Carlos de Souza Ferreira, Marianna Teixeira de Pinho Favaro · 2023 · ACS Applied Nano Materials
74. Universal subunit vaccine protects against multiple SARS-CoV-2 variants and SARS-CoV
    Gang Wang, Abhishek Kumar Verma, Juan Shi, Xiaoqing Guan, David Kyle Meyerholz, Fan Bu, Wei Wen, Bin Liu, Fang Li, Stanley M. Perlman et al. · 2024 · npj Vaccines
75. Emergence and Reemergence of Severe Acute Respiratory Syndrome (SARS) Coronaviruses
    Preeti Baxi, Shailendra Kumar Saxena · 2020 · Medical virology
76. Screening the General Population for SARS-CoV-2 Virus and COVID-19 Antibodies: A Counterargument
    Alan H.B. Wu · 2020 · The Journal of Applied Laboratory Medicine
77. New insights on possible vaccine development against SARS-CoV-2
    Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, Shahid Bilal, Nauman Zafar, Aleena Siddique, Ayesha Zafar · 2020 · Life Sciences
78. Tropical Food Spices: A Promising Panacea for the Novel Coronavirus Disease (COVID‐19)
    Adedayo Oluwaseun Ademiluyi, Olubukola Helen Oyeniran, Ganiyu Oboh · 2020 · eFood
79. Clinical Application of Serologic Testing for Coronavirus Disease 2019 in Contemporary Cardiovascular Practice
    Abdulla A. Damluji, Robert H. Christenson, Christopher R. deFilippi · 2021 · Journal of the American Heart Association
80. Spike protein mutational landscape in India during the complete lockdown phase: Could Muller's ratchet be a future game-changer for COVID-19?
    Rachana Banerjee, Kausik Basak, Anamika Ghosh, Vyshakh Rajachandran, Kamakshi Sureka, Debabani Ganguly, Sujay Chattopadhyay · 2021 · Infection Genetics and Evolution
81. The Recent Updates on Approaches and Clinical Trials Status of Covid-19 Vaccines Developed Globally
    Sachin Chaudhary, Abdel‐Nasser El‐Shorbagi, Ramesh Kumar Gupta, Amit Kumar · 2021 · Biomedical & Pharmacology Journal
82. Cardiovascular complications after COVID-19 in chronic kidney disease, dialysis and kidney transplant patients
    Charalampos Loutradis, Apostolos G. Pitoulias, Eleni Pagkopoulou, Georgios A. Pitoulias · 2021 · International Urology and Nephrology
83. Identification of Compounds from Curcuma longa with In Silico Binding Potential against SARS-CoV-2 and Human Host Proteins Involve in Virus Entry and Pathogenesis
    S. Kumar, Atul Kumar Singh, Prem Prakash Kushwaha, Kumari Sunita Prajapati, S. Senapati, Sofian-Azirun Mohd, S. Gupta · 2021 · Indian Journal of Pharmaceutical Sciences
84. Allosteric Determinants of the SARS-CoV-2 Spike Protein Binding with Nanobodies: Examining Mechanisms of Mutational Escape and Sensitivity of the Omicron Variant
    Gennady M. Verkhivker · 2022 · International Journal of Molecular Sciences
85. COVID-19 in G6PD-deficient Patients, Oxidative Stress, and Neuropathology
    Beatriz Hernández‐Ochoa, Daniel Ortega-Cuéllar, Abigail González‐Valdez, Noemí Cárdenas‐Rodríguez, Julieta Griselda Mendoza‐Torreblanca, Itzel Jatziri Contreras‐García, Luz Adriana Pichardo‐Macías, Cindy Bandala, Saúl Gómez‐Manzo · 2022 · Current Topics in Medicinal Chemistry
86. Towards Quantum-Chemical Level Calculations of SARS-CoV-2 Spike Protein Variants of Concern by First Principles Density Functional Theory
    W. Y. Ching, Puja Adhikari, Bahaa Jawad, Rudolf Podgornik · 2023 · Biomedicines
87. Assessment of the Biological Impact of SARS-CoV-2 Genetic Variation Using an Authentic Virus Neutralisation Assay with Convalescent Plasma, Vaccinee Sera, and Standard Reagents
    Naomi S. Coombes, Kevin R. Bewley, Yann Le Duff, Matthew Hurley, Lauren J. Smith, Thomas M. Weldon, Karen L. Osman, Steven T. Pullan, Neil J. Berry, Bassam Hallis et al. · 2023 · Viruses
88. Computational design of nanomolar-binding antibodies specific to multiple SARS-CoV-2 variants by engineering a specificity switch of antibody 80R using RosettaAntibodyDesign (RAbD) results in potential generalizable therapeutic antibodies for novel SARS-CoV-2 virus
    Nancy E. Hernandez, Wojciech Jankowski, Rahel Frick, Simon P. Kelow, Joseph H. Lubin, Vijaya Lakshmi Simhadri, Jared Adolf‐Bryfogle, Sagar D. Khare, Roland L. Dunbrack, Jeffrey J. Gray et al. · 2023 · Heliyon
89. CHO-produced RBD-Fc subunit vaccines with alternative adjuvants generate immune responses against SARS-CoV-2
    Sedthawut Laotee, Methawee Duangkaew, Araya Jivapetthai, Kittipan Tharakhet, Papatsara Kaewpang, Eakachai Prompetchara, Supaporn Phumiamorn, Sompong Sapsutthipas, Sakalin Trisiriwanich, Thitiporn Somsaard et al. · 2023 · PLoS ONE
90. Deglycosylated RBD produced in Pichia pastoris as a low-cost sera COVID-19 diagnosis tool and a vaccine candidate
    Tommy Idrovo-Hidalgo, María Florencia Pignataro, Luis M. Bredeston, Fernanda Elias, María Georgina Herrera, María Florencia Pavan, Sabrina Foscaldi, Mayra Suireszcz, Natalia Fernández, Diana E. Wetzler et al. · 2023 · Glycobiology
91. Infrared Spectroscopy of SARS‐CoV‐2 Viral Protein: from Receptor Binding Domain to Spike Protein
    Tiziana Mancini, Salvatore Macis, Rosanna Mosetti, Nicole Luchetti, Velia Minicozzi, A. Notargiacomo, Marialilia Pea, A. Marcelli, Giancarlο Della Ventura, S. Lupi et al. · 2024 · Advanced Science
92. Insights of Novel Coronavirus (SARS-CoV-2) disease outbreak, management and treatment
    Dharmender Kumar, Lalit Batra, Mohammad Tariq Malik · 2020 · AIMS Microbiology
93. Can data from paediatric cohorts solve the COVID-19 puzzle?
    Lien Anh Ha Do, Jeremy Anderson, Kim Mulholland, Paul Vincent Licciardi · 2020 · PLoS Pathogens
94. Molecular targets and system biology approaches for drug repurposing against SARS-CoV-2
    RAHUL KUNWAR SINGH, Brijesh Singh Yadav, Tribhuvan Mohan Mohapatra · 2020 · Bulletin of the National Research Centre/Bulletin of the National Research Center
95. The interplay between the immune system and SARS-CoV-2 in COVID-19 patients
    Sana Shabbir, Muhammad Hassan Raza, Muhammad Arshad, Muhammad Jawad Khan · 2021 · Archives of Virology
96. Structure-Based Virtual Screening and Molecular Dynamics Simulation to Identify Potential SARS-CoV-2 Spike Receptor Inhibitors from Natural Compound Database
    Arkadeep Sarkar, Debanjan Sen, Ashutosh Kumar Sharma, Ravikumar Muttineni, Sudhan Debnath · 2021 · Pharmaceutical Chemistry Journal
97. Epidemic Preparedness—Leishmania tarentolae as an Easy-to-Handle Tool to Produce Antigens for Viral Diagnosis: Application to COVID-19
    Ilaria Varotto-Boccazzi, Alessandro Manenti, Francesca Dapporto, Louise J. Gourlay, Beatrice Bisaglia, Paolo Gabrieli, Federico Forneris, Silvia Faravelli, Valentina Bollati, Diego Rubolini et al. · 2021 · Frontiers in Microbiology
98. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas
    Abdouramane Traoré, Merepen A. Guindo, Drissa S Konate, Bourama Traoré, Seidina A. S. Diakité, Salimata Kanté, Assitan Dembélé, Abdourhamane Cissé, Nathan C. Incandela, Mamoudou Kodio et al. · 2022 · Frontiers in Immunology
99. Recombinant Protein Technology in the Challenging Era of Coronaviruses
    Ace Bryan Sotelo Cabal, Tzong‐Yuan Wu · 2022 · Processes
100. Virological and Clinical Determinants of the Magnitude of Humoral Responses to SARS-CoV-2 in Mild-Symptomatic Individuals
     Edwards Pradenas, Maria Ubals, V. Urrea, C. Suñer, B. Trinité, E. Riveira-Muñoz, S. Marfil, C. Ávila-Nieto, M. L. Rodríguez de la Concepción, F. Tarrés-Freixas et al. · 2022 · Frontiers in Immunology